Table 3 Association of NSAID use with COVID-19 outcomes as measured by logistic regression. AKI: acute kidney injury; ECMO: extracorporeal membrane oxygenation
From: NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study
| Â | OR (95% CI) | p value |
|---|---|---|
COVID severity (severe or dead) | 0.57 (0.53–0.61) | < 0.0001 |
Mortality/hospice | 0.51 (0.47–0.56) | < 0.0001 |
Invasive ventilation | 0.59 (0.55–0.64) | < 0.0001 |
AKI | 0.67 (0.63–0.72) | < 0.0001 |
ECMO | 0.51 (0.36–0.7) | < 0.0001 |